Conversations that Convert: 2024 Physician Survey on HCP+DTC Pharma Marketing Strategies 

OptimizeRx commissioned an independent survey of 170+ physicians, exploring their perception of direct-to-consumer pharma marketing strategies, how patients engage with and consume health information, and how it impacts their treatment experience. The results revealed a key, untapped opportunity synchronizing HCP and DTC pharma marketing. 


Sample Data and Insights from the Research 

HCPs welcome engaged, informed patients. But our 2024 survey reveals they’re also skeptical of the quality of information patients consume and cite a number of factors impacting the physician / patient conversation. However, when information and timing align, these conversations can transform treatment.  

In fact, synchronizing engagement with HCPs and patients is a powerful opportunity hiding in plain sight. But first, we need to move beyond the marketing silos that separate the two. Here are the top findings from the survey; download the full white paper to see the implications and actions for pharma brands. 
ClinicalConnectionWP-LP-Header_Header-1

  • 45% of physicians agree that patient-sourced information may cause them to consider new treatments
  • 73% of physicians say the medications patients request are only sometimes, occasionally, or rarely appropriate 
  • 70% of physicians believe aligning the information HCPs and patients receive from brands streamlines care 
  • 13% of physicians think there is currently strong alignment between HCP and DTC marketing